Symbol	pid	phase	info	pit
PIK3CA	0.33999999999999997	4	alpelisib [PI3-kinase p110-alpha subunit inhibitor] (breast carcinoma); copanlisib hydrochloride [PI3-kinase p110-alpha subunit inhibitor] (follicular lymphoma)	3.69063861685359
PLCB1	0.28	NA	NA	3.07554768474766
CXCR2	0.16000000000000003	3	ladarixin [Interleukin-8 receptor B modulator] (type 1 diabetes mellitus); reparixin [Interleukin-8 receptor B modulator] (type 1 diabetes mellitus | viral pneumonia)	3.93946540006464
GNAQ	0.06000000000000005	NA	NA	3.59208202437127
CXCR4	0.040000000000000036	4	plerixafor [C-X-C chemokine receptor type 4 partial agonist] (acute lymphoblastic leukemia | multiple myeloma | non-Hodgkins lymphoma)	4.05732741803509
JAK2	0.040000000000000036	4	baricitinib [Tyrosine-protein kinase JAK2 inhibitor] (rheumatoid arthritis | immune system disease); fedratinib hydrochloride [Tyrosine-protein kinase JAK2 inhibitor] (Myelofibrosis | primary myelofibrosis); pacritinib citrate [Tyrosine-protein kinase JAK2 inhibitor] (polycythemia vera | primary myelofibrosis); ruxolitinib phosphate [Tyrosine-protein kinase JAK2 inhibitor] (Myelofibrosis | polycythemia vera | primary myelofibrosis); tofacitinib citrate [Janus Kinase (JAK) inhibitor] (rheumatoid arthritis | psoriatic arthritis); upadacitinib [Janus Kinase (JAK) inhibitor] (rheumatoid arthritis | immune system disease)	3.99798209320993
IFNB1	0.040000000000000036	NA	NA	3.80961527531335
IFNAR2	0.020000000000000018	4	interferon alfa-2b [Interferon alpha/beta receptor agonist] (anogenital venereal wart | chronic hepatitis B virus infection | chronic hepatitis C virus infection | cutaneous melanoma | follicular lymphoma | hairy cell leukemia | hepatitis B virus infection | Kaposi's sarcoma | melanoma); interferon beta-1a [Interferon alpha/beta receptor agonist] (multiple sclerosis); interferon beta-1b [Interferon alpha/beta receptor agonist] (multiple sclerosis); peginterferon alfa-2a [Interferon alpha/beta receptor agonist] (chronic hepatitis B virus infection | chronic hepatitis C virus infection | hepatitis B virus infection); peginterferon alfa-2b [Interferon alpha/beta receptor agonist] (chronic hepatitis C virus infection | cutaneous melanoma | melanoma | metastatic melanoma); peginterferon beta-1a [Interferon alpha/beta receptor agonist] (multiple sclerosis); ropeginterferon alfa-2b [Interferon alpha/beta receptor positive modulator] (polycythemia vera)	4.57152504271816
TYK2	0.020000000000000018	4	deucravacitinib [Tyrosine-protein kinase TYK2 negative allosteric modulator] (psoriasis); tofacitinib citrate [Janus Kinase (JAK) inhibitor] (rheumatoid arthritis | psoriatic arthritis); upadacitinib [Janus Kinase (JAK) inhibitor] (rheumatoid arthritis | immune system disease)	4.22528526042096
IFNAR1	0.020000000000000018	4	anifrolumab [Interferon-alpha/beta receptor alpha chain antagonist] (systemic lupus erythematosus | immune system disease); interferon alfa-2b [Interferon alpha/beta receptor agonist] (anogenital venereal wart | chronic hepatitis B virus infection | chronic hepatitis C virus infection | cutaneous melanoma | follicular lymphoma | hairy cell leukemia | hepatitis B virus infection | Kaposi's sarcoma | melanoma); interferon beta-1a [Interferon alpha/beta receptor agonist] (multiple sclerosis); interferon beta-1b [Interferon alpha/beta receptor agonist] (multiple sclerosis); peginterferon alfa-2a [Interferon alpha/beta receptor agonist] (chronic hepatitis B virus infection | chronic hepatitis C virus infection | hepatitis B virus infection); peginterferon alfa-2b [Interferon alpha/beta receptor agonist] (chronic hepatitis C virus infection | cutaneous melanoma | melanoma | metastatic melanoma); peginterferon beta-1a [Interferon alpha/beta receptor agonist] (multiple sclerosis); ropeginterferon alfa-2b [Interferon alpha/beta receptor positive modulator] (polycythemia vera)	4.18981777934423
JAK3	0.020000000000000018	4	tofacitinib citrate [Janus Kinase (JAK) inhibitor] (rheumatoid arthritis | psoriatic arthritis); upadacitinib [Janus Kinase (JAK) inhibitor] (rheumatoid arthritis | immune system disease)	4.06007746213595
IL6	0.020000000000000018	4	siltuximab [Interleukin-6 inhibitor] (Castleman disease | Giant Lymph Node Hyperplasia | immune system disease)	3.98278873574324
IL13	0.020000000000000018	4	tralokinumab [Interleukin-13 inhibitor] (atopic eczema | Eczema)	3.93898192297953
IFNGR2	0.020000000000000018	4	interferon gamma-1b [Interferon gamma receptor agonist] (Albers-Schonberg osteopetrosis | chronic granulomatous disease | osteopetrosis)	3.92122836603689
JAK1	0.020000000000000018	4	abrocitinib [Tyrosine-protein kinase JAK1 inhibitor] (atopic eczema | Eczema); baricitinib [Tyrosine-protein kinase JAK1 inhibitor] (rheumatoid arthritis | immune system disease); filgotinib [Tyrosine-protein kinase JAK1 inhibitor] (immune system disease); ruxolitinib phosphate [Tyrosine-protein kinase JAK1 inhibitor] (Myelofibrosis | polycythemia vera | primary myelofibrosis); tofacitinib citrate [Janus Kinase (JAK) inhibitor] (rheumatoid arthritis | psoriatic arthritis); upadacitinib [Janus Kinase (JAK) inhibitor] (rheumatoid arthritis | immune system disease)	3.86330126306507
IFNG	0.020000000000000018	4	emapalumab [Interferon gamma inhibitor] (hemophagocytic syndrome | immune system disease | Primary hemophagocytic lymphohistiocytosis)	3.83068058011329
IFNGR1	0.020000000000000018	4	interferon gamma-1b [Interferon gamma receptor agonist] (Albers-Schonberg osteopetrosis | chronic granulomatous disease | osteopetrosis)	3.80837833493845
IL10RB	0.020000000000000018	3	pegilodecakin [IL-10 receptor agonist] (pancreatic carcinoma); peginterferon lambda-1a [Interferon lambda receptor agonist] (chronic hepatitis C virus infection | hepatitis C virus infection | hepatitis D virus infection | severe acute respiratory syndrome)	4.59990819360238
CSF2	0.020000000000000018	3	lenzilumab [Granulocyte-macrophage colony-stimulating factor inhibitor] (pneumonia); otilimab [Granulocyte-macrophage colony-stimulating factor inhibitor] (rheumatoid arthritis); pexastimogene devacirepvec [Granulocyte-macrophage colony-stimulating factor vaccine antigen] (hepatocellular carcinoma)	4.02153477724587
IL10RA	0.020000000000000018	3	pegilodecakin [IL-10 receptor agonist] (pancreatic carcinoma)	3.89679454988146
IL10	0.020000000000000018	NA	NA	4.21547193766576
PTPN6	0.020000000000000018	NA	NA	4.16328065614169
PTPN11	0.020000000000000018	NA	NA	4.10658782214429
CXCL12	0.020000000000000018	NA	NA	4.05923970180982
STAT3	0.020000000000000018	NA	NA	4.04159616064855
CXCL6	0.020000000000000018	NA	NA	4.02871952760903
PLCG1	0.020000000000000018	NA	NA	4.011248414439
CXCL2	0.020000000000000018	NA	NA	4.00432424789507
CXCL1	0.020000000000000018	NA	NA	4.00170000419002
STAT2	0.020000000000000018	NA	NA	3.98707846301196
IL4	0.020000000000000018	NA	NA	3.95147020499427
PPBP	0.020000000000000018	NA	NA	3.95075961831298
CXCL5	0.020000000000000018	NA	NA	3.93026785336777
STAT1	0.020000000000000018	NA	NA	3.92924423799994
CXCL8	0.020000000000000018	NA	NA	3.92628782631207
IRF1	0.020000000000000018	NA	NA	3.92547378628004
IFNA17	0.020000000000000018	NA	NA	3.92030566931272
IFNA21	0.020000000000000018	NA	NA	3.90027270447444
IFNA2	0.020000000000000018	NA	NA	3.89637256749893
GNB1	0.020000000000000018	NA	NA	3.88888413515469
IFNK	0.020000000000000018	NA	NA	3.88415816104922
IFNL2	0.020000000000000018	NA	NA	3.88037059752411
CXCL3	0.020000000000000018	NA	NA	3.87816171428761
STAT6	0.020000000000000018	NA	NA	3.87181164070015
IFNL3	0.020000000000000018	NA	NA	3.86485477735946
IFNL1	0.020000000000000018	NA	NA	3.86050975633203
IFNW1	0.020000000000000018	NA	NA	3.85827534491543
GNAI2	0.020000000000000018	NA	NA	3.85430508378835
GNG2	0.020000000000000018	NA	NA	3.84374520182797
IL2	0.020000000000000018	NA	NA	3.83062536243738